- 全部删除
您的购物车当前为空
Lixudebart是一种靶向CLDN1(Claudin-1)的人源化单克隆抗体,可用于逆转器官纤维化(如肺纤维化),能够降低ALT/AST的初始水平。

为众多的药物研发团队赋能,
让新药发现更简单!
Lixudebart是一种靶向CLDN1(Claudin-1)的人源化单克隆抗体,可用于逆转器官纤维化(如肺纤维化),能够降低ALT/AST的初始水平。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,480 | In stock | |
| 5 mg | ¥ 5,860 | In stock | |
| 10 mg | ¥ 7,890 | In stock | |
| 25 mg | ¥ 11,700 | In stock | |
| 50 mg | ¥ 15,800 | In stock |
| 产品描述 | Lixudebart is a humanised monoclonal antibody targeting CLDN1 (Claudin-1), which can be used to reverse organ fibrosis (such as pulmonary fibrosis) and reduce initial ALT/AST levels. |
| 别名 | 立尤德拜单抗, ALE-F02, ALEF02, ALE.F02 |
| CAS No. | 2749515-10-2 |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容